Go green in Ghana ‘forestmaker’ Tonyrinaudo with world vision on site at Knauer

Au­to­lus Ther­a­peu­tics is ex­pect­ing an FDA de­ci­sion on Nov. 16 for obe­cab­ta­gene au­toleu­cel (obe-cel), its CAR-T hope­ful that would ri­val Gilead’s Tecar­tus in adult acute

Chronic heavy drinkers in middle age had better chances of dodging atrial fibrillation (Afib or AF) if they quit alcohol instead of drinking less of